These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26912815)

  • 41. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors.
    Perin-Dureau F; Rachline J; Neyton J; Paoletti P
    J Neurosci; 2002 Jul; 22(14):5955-65. PubMed ID: 12122058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Positive Modulators of the N-Methyl-d-aspartate Receptor: Structure-Activity Relationship Study of Steroidal 3-Hemiesters.
    Krausova B; Slavikova B; Nekardova M; Hubalkova P; Vyklicky V; Chodounska H; Vyklicky L; Kudova E
    J Med Chem; 2018 May; 61(10):4505-4516. PubMed ID: 29708744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics.
    Ugale V; Deshmukh R; Lokwani D; Narayana Reddy P; Khadse S; Chaudhari P; Kulkarni PP
    Mol Divers; 2024 Jun; 28(3):1765-1792. PubMed ID: 37266849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting NMDA receptor in Alzheimer's disease: identifying novel inhibitors using computational approaches.
    Siddiqui AJ; Badraoui R; Jahan S; Alshahrani MM; Siddiqui MA; Khan A; Adnan M
    Front Pharmacol; 2023; 14():1208968. PubMed ID: 37416066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents.
    El Fadili M; Er-Rajy M; Ali Eltayb W; Kara M; Imtara H; Zarougui S; Al-Hoshani N; Hamadi A; Elhallaoui M
    J Biomol Struct Dyn; 2024 Aug; 42(12):6174-6188. PubMed ID: 37428078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic variation of the benzoylhydrazine moiety of the GluN2A selective NMDA receptor antagonist TCN-201.
    Schreiber JA; Müller SL; Westphälinger SE; Schepmann D; Strutz-Seebohm N; Seebohm G; Wünsch B
    Eur J Med Chem; 2018 Oct; 158():259-269. PubMed ID: 30218911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water.
    Mesbahi-Vasey S; Veras L; Yonkunas M; Johnson JW; Kurnikova MG
    PLoS One; 2017; 12(6):e0177686. PubMed ID: 28582391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.
    Kaiser TM; Kell SA; Kusumoto H; Shaulsky G; Bhattacharya S; Epplin MP; Strong KL; Miller EJ; Cox BD; Menaldino DS; Liotta DC; Traynelis SF; Burger PB
    Mol Pharmacol; 2018 Feb; 93(2):141-156. PubMed ID: 29242355
    [No Abstract]   [Full Text] [Related]  

  • 50. Metabolism studies of ifenprodil, a potent GluN2B receptor antagonist.
    Falck E; Begrow F; Verspohl E; Wünsch B
    J Pharm Biomed Anal; 2014 Jan; 88():96-105. PubMed ID: 24042122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple domains in the C-terminus of NMDA receptor GluN2B subunit contribute to neuronal death following in vitro ischemia.
    Vieira MM; Schmidt J; Ferreira JS; She K; Oku S; Mele M; Santos AE; Duarte CB; Craig AM; Carvalho AL
    Neurobiol Dis; 2016 May; 89():223-34. PubMed ID: 26581639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.
    Lü W; Du J; Goehring A; Gouaux E
    Science; 2017 Mar; 355(6331):. PubMed ID: 28232581
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanism of NMDA Receptor Inhibition and Activation.
    Zhu S; Stein RA; Yoshioka C; Lee CH; Goehring A; Mchaourab HS; Gouaux E
    Cell; 2016 Apr; 165(3):704-14. PubMed ID: 27062927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor.
    Wee XK; Ng KS; Leung HW; Cheong YP; Kong KH; Ng FM; Soh W; Lam Y; Low CM
    Br J Pharmacol; 2010 Jan; 159(2):449-61. PubMed ID: 20082612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold.
    Gawaskar S; Temme L; Schreiber JA; Schepmann D; Bonifazi A; Robaa D; Sippl W; Strutz-Seebohm N; Seebohm G; Wünsch B
    ChemMedChem; 2017 Aug; 12(15):1212-1222. PubMed ID: 28749574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons.
    Neagoe I; Liu C; Stumpf A; Lu Y; He D; Francis R; Chen J; Reynen P; Alaoui-Ismaili MH; Fukui H
    Stem Cell Res; 2018 Apr; 28():105-114. PubMed ID: 29454156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
    Izumi Y; Zorumski CF
    J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
    Strong KL; Epplin MP; Bacsa J; Butch CJ; Burger PB; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2017 Jul; 60(13):5556-5585. PubMed ID: 28586221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.
    Temme L; Frehland B; Schepmann D; Robaa D; Sippl W; Wünsch B
    Eur J Med Chem; 2018 Jan; 144():672-681. PubMed ID: 29289890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain.
    Stroebel D; Carvalho S; Paoletti P
    Neuropharmacology; 2011 Jan; 60(1):151-8. PubMed ID: 20621105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.